Premier Health of America Inc.

    Premier Health of America Inc.

    TTSXV:PHA
    - -
    CAD
    - -
    - -
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    0.61
    1.34
    1.46
    1.62
    2.85
    1.84
    1.58
    Basic EPS, GAAP
    - -
    - -
    -0.14
    - -
    0.03
    - -
    -0.03
    -0.23
    -0.28
    -0.28
    Free Cash Flow per Basic Share
    - -
    - -
    -0.09
    0.01
    - -
    0.06
    -0.06
    0.13
    0.18
    0.21
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.03
    0.03
    0.03
    0.1
    0.32
    0.33
    0.3
    0.07
    -0.2
    -0.25
    Tangible Book Value per Share
    0.03
    0.03
    0.03
    0.07
    -0.04
    -0.16
    -0.14
    -0.53
    -0.65
    -0.68
    Basic Weighted Avg Shares
    - -
    5
    2
    34
    50
    55
    56
    55
    56
    56
    Sales/Revenue/Turnover
    - -
    - -
    - -
    21
    67
    81
    90
    158
    102
    88
    Operating Margin (%)
    - -
    - -
    - -
    9.51
    5.16
    2.9
    3.65
    -0.28
    -8.43
    -10.55
    Depreciation Expense
    - -
    - -
    - -
    - -
    2
    3
    4
    7
    8
    8
    Net Income, GAAP
    - -
    - -
    - -
    - -
    1
    - -
    -2
    -12
    -15
    -16
    Effective Tax Rate (%)
    - -
    - -
    - -
    93.67
    40.64
    109.02
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    0.13
    2.25
    -0.14
    -1.88
    -7.89
    -15.14
    -17.94
    Working Capital
    - -
    - -
    - -
    2
    8
    13
    15
    -21
    -31
    -33
    LT Debt
    - -
    - -
    - -
    1
    12
    22
    26
    3
    1
    1
    Total Equity
    - -
    - -
    - -
    4
    17
    18
    16
    4
    -11
    -14
    Return on Invested Capital (%)
    - -
    - -
    - -
    3.41
    10.76
    -0.57
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    1.2
    11.27
    -0.56
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    -12.72
    -199.06
    1.39
    14.13
    -0.63
    -9.76
    -121.74
    - -
    -191.46

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'26
    ST Debt
    44
    43
    43
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    1
    1
    1
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    56
    56
    56
    Market Capitalization
    3
    2
    1

    Working Capital

    CAD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'26
    Total Current Assets
    23
    21
    17
    Cash, Cash Equivalents & STI
    1
    1
    - -
    Accounts Receivable, Net
    19
    17
    15
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    51
    52
    51
    Payables & Accruals
    6
    8
    7
    ST Debt
    44
    43
    43
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -21.74%
    -376.57%
    Free Cash Flow
    - -
    2,667.4%
    35.65%
    Net Income, GAAP
    - -
    1,446.14%
    23.66%
    Sales/Revenue/Turnover
    - -
    58.77%
    -35.54%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    37
    46
    41
    33
    158
    2025
    32
    27
    22
    21
    102
    2026
    18
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    -0.03
    -0.15
    - -
    -0.23
    2025
    -0.04
    -0.06
    -0.06
    - -
    -0.28
    2026
    -0.05
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business

    Company News